2.5. Endpoints
The predefined primary objective of this trial was to investigate the gastrointestinal tolerability of oligomalt when consumed daily for 7 consecutive days at two different dosages (80 g/day in combination with 100 g of maltodextrin/day and 180 g/day, respectively) as compared to maltodextrin (180 g/day), based on the GSRS questionnaire [